Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Applied Genetic Technologies	X4 Pharmaceuticals	ERYTECH Pharma	BiomX	Champions Oncology
Symbol	NASDAQ:AGTC	NASDAQ:XFOR	NASDAQ:ERYP	NYSEMKT:PHGE	NASDAQ:CSBR
Price Information
Current Price	$3.81	$8.00	$7.03	$5.91	$10.12
52 Week Range	Buy	Buy	N/A	Buy	Buy
MarketRank™
Overall Score	1.5	1.8	0.5	0.6	1.8
Analysis Score	3.5	3.5	0.0	0.0	3.5
Community Score	3.0	2.8	2.1	2.9	2.2
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	1.7	0.0	0.0	1.7
Earnings & Valuation Score	0.0	1.3	0.6	0.0	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	Buy	Buy
Consensus Price Target	$17.58	$18.00	N/A	$25.00	$16.00
% Upside from Price Target	361.50% upside	125.00% upside	N/A	323.01% upside	58.10% upside
Trade Information
Market Cap	$162.89 million	$139.07 million	$151.99 million	$137.41 million	$135.51 million
Beta	2.33	0.53	2.73	0.48	1.2
Average Volume	2,624,572	106,062	20,492	25,236	31,194
Sales & Book Value
Annual Revenue	$2.45 million	N/A	N/A	N/A	$32.12 million
Price / Sales	66.48	N/A	N/A	N/A	4.22
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.76 per share	$10.37 per share	$5.34 per share	$3.83 per share	$0.45 per share
Price / Book	1.38	N/A	N/A	N/A	22.49
Profitability
Net Income	$-45,890,000.00	$-52,810,000.00	$-70,180,000.00	$-20,560,000.00	$-1,980,000.00
EPS	($2.17)	($4.63)	($3.92)	($3.66)	($0.17)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	67.47
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	-4.18%
Return on Equity (ROE)	-73.06%	-47.06%	N/A	-39.95%	-29.93%
Return on Assets (ROA)	-53.25%	-35.89%	N/A	-36.65%	-7.41%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.17%	0.24%	0.09%	N/A	N/A
Current Ratio	5.27%	10.19%	2.39%	13.87%	1.18%
Quick Ratio	5.27%	10.19%	2.37%	13.87%	1.18%
Ownership Information
Institutional Ownership Percentage	57.88%	67.76%	6.47%	26.78%	52.84%
Insider Ownership Percentage	7.50%	4.90%	N/A	23.20%	46.80%
Miscellaneous
Employees	83	72	206	95	143
Shares Outstanding	42.75 million	17.38 million	21.62 million	23.25 million	13.39 million
Next Earnings Date	5/12/2021 (Estimated)	7/29/2021 (Estimated)	N/A	N/A	7/26/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Halozyme Therapeutics (NASDAQ:HALO) & Champions Oncology (NASDAQ:CSBR) Head to Head Analysis americanbankingnews.com - May 3 at 12:24 PM
	Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation finance.yahoo.com - April 29 at 8:58 AM
	Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com - April 16 at 1:21 PM
	Macungie contestant who won $109,000 on ‘Jeopardy’ returning for game show’s Tournament of Champions mcall.com - April 15 at 10:46 PM
	'Jeopardy!' taps Buzzy Cohen as guest host for Tournament of Champions news.yahoo.com - April 15 at 10:46 PM
	Champions Oncology Stock Is Estimated To Be Fairly Valued finance.yahoo.com - April 10 at 11:51 PM
	CR Belouizdad into quarter-finals as Al Hilal exit CAF Champions League en.as.com - April 10 at 6:50 PM
	Podcast of Champions - Pac-12 commissioner search rolls on while UCLA goes from First Four to Final Four 247sports.com - April 10 at 6:50 PM
	Report: Harry Kane to Push for Transfer If Tottenham Miss out on Champions League bleacherreport.com - April 10 at 6:50 PM
	Robert Lewandowski confirms he will NOT be fit to rescue Bayern next week after Champions League loss to PSG the-sun.com - April 10 at 6:50 PM
	Sailing Champions League Asia Pacific set for thriller final mysailing.com.au - April 10 at 6:50 PM
	Thomas Tuchel sends Chelsea squad message ahead of Porto clash in Champions League si.com - April 10 at 6:50 PM
	Happy Birthday to our Champions for Saturday, April 10 localsyr.com - April 10 at 6:50 PM
	Milan survive Ibrahimovic sending off to stay in Champions League chase sports.yahoo.com - April 10 at 6:50 PM
	African Champions League: CR Belouizdad join Sundowns in quarter-finals bbc.com - April 10 at 3:49 AM
	Chelsea tipped to win Champions League this season si.com - April 10 at 3:49 AM
	Chelsea vs Porto: UEFA Champions League background, form guide, previous meetings uefa.com - April 10 at 3:49 AM
	Navajo Shooter Sports Team welcomed home as Shooter Sports State Champions kswo.com - April 10 at 3:49 AM
	FIFA 21 Champions League Team of the Tournament: Knockout Stage squad, release date & predictions msn.com - April 10 at 3:49 AM
	AP source: Portland gets Women’s International Champions Cup islandpacket.com - April 10 at 3:49 AM
	Romance of the Champions Cup has England legend Mark Cueto back in love with Sale Sharks the-sun.com - April 10 at 3:49 AM
	KENS CARES: Methodist Children's Hospital seeks kids to honor as 'Champions for Change' kens5.com - April 10 at 3:49 AM
	Community Champions: Korn Ferry Tour pro starts fundraiser for Lupus research msn.com - March 25 at 10:42 PM
	FIFPRO: Rules to protect players’ health must be part of Champions League revamp sports.yahoo.com - March 23 at 5:11 AM
	Chelsea vs. Atletico Madrid on Paramount+: Live stream UEFA Champions League, how to watch on TV, odds, news cbssports.com - March 17 at 11:42 AM

Date	Company	Brokerage	Action
3/8/2021	Applied Genetic Technologies	Stifel Nicolaus	Initiated Coverage
2/2/2021	Applied Genetic Technologies	HC Wainwright	Boost Price Target
2/1/2021	Applied Genetic Technologies	Roth Capital	Boost Price Target
11/20/2020	Applied Genetic Technologies	Berenberg Bank	Reiterated Rating
7/22/2020	Applied Genetic Technologies	Chardan Capital	Reiterated Rating
6/22/2020	Applied Genetic Technologies	Cantor Fitzgerald	Initiated Coverage
1/24/2020	Applied Genetic Technologies	Janney Montgomery Scott	Reiterated Rating
1/9/2020	Applied Genetic Technologies	Wedbush	Reiterated Rating
1/9/2020	Applied Genetic Technologies	BMO Capital Markets	Boost Price Target
3/22/2021	X4 Pharmaceuticals	Oppenheimer	Reiterated Rating
12/17/2020	X4 Pharmaceuticals	Brookline Capital Management	Initiated Coverage
11/30/2020	X4 Pharmaceuticals	B. Riley	Reiterated Rating
11/9/2020	X4 Pharmaceuticals	Canaccord Genuity	Lower Price Target
3/26/2020	X4 Pharmaceuticals	Citigroup	Lower Price Target
3/12/2020	X4 Pharmaceuticals	Cowen	Reiterated Rating
9/5/2019	ERYTECH Pharma	JMP Securities	Reiterated Rating
4/21/2021	BiomX	LADENBURG THALM/SH SH	Initiated Coverage
11/27/2019	Champions Oncology	Benchmark	Initiated Coverage
2/27/2019	Champions Oncology	National Securities	Initiated Coverage
7/17/2018	Champions Oncology	Craig Hallum	Initiated Coverage
5/15/2018	Champions Oncology	Dawson James	Initiated Coverage

(Data available from 5/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources